Nontransvenous Cardiovascular Implantable Electronic Device Technology-A Review for the Anesthesiologist.

Abstract There is a recent shift in bradycardia pacing and defibrillation therapy to leadless pacemakers and extrathoracic cardioverter-defibrillator technology due to complications associated with transvenous devices. These innovations have implications for anesthesia care, as these novel devices have design and functionality features different from transvenous devices. Current perioperative guidelines do not address management of leadless pacemakers and the subcutaneous implantable cardioverter-defibrillator, although implantation rates are increasing globally. This article addresses the features and functionality of non-transvenous cardiac implantable electronic devices such as the Micra and the subcutaneous implantable cardioverter-defibrillator, and provides guidance for perioperative management.